Itau Unibanco Holding S.A. Roivant Sciences Ltd. Transaction History

Itau Unibanco Holding S.A.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$10.36 - $11.74 $15,622 - $17,703	1,508 New	1,508 $15,000
Q4 2023 Feb 14, 2024	SELL	$8.38 - $11.58 $3,486 - $4,817	-416 Reduced 14.81%	2,393 $26,000
Q3 2023 Nov 14, 2023	BUY	$9.76 - $13.19 $6,695 - $9,048	686 Added 32.31%	2,809 $32,000
Q2 2023 Aug 14, 2023	SELL	$7.09 - $10.08 $6,253 - $8,890	-882 Reduced 29.35%	2,123 $21,000
Q1 2023 May 12, 2023	SELL	$6.92 - $9.98 $117 - $169	-17 Reduced 0.56%	3,005 $22,000
Q4 2022 Feb 09, 2023	SELL	$3.36 - $7.99 $2,496 - $5,936	-743 Reduced 19.73%	3,022 $24,000
Q3 2022 Nov 14, 2022	BUY	$0.51 - $4.84 $1,920 - $18,222	3,765 New	3,765 $12,000

319

507M

1.26M

2.52M

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $7.84B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.